Alps Advisors Inc Ironwood Pharmaceuticals Inc Transaction History
Alps Advisors Inc
- $17.2 Billion
- Q1 2025
A detailed history of Alps Advisors Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Alps Advisors Inc holds 116,860 shares of IRWD stock, worth $108,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
116,860
Previous 129,397
9.69%
Holding current value
$108,679
Previous $573,000
70.16%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IRWD
# of Institutions
234Shares Held
162MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$21.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$18.2 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$15.2 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$10.9 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$8.81 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $143M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...